Related Experiment Video
Updated: May 20, 2026

06:06
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
The return of rainbow diet pills
Pieter A Cohen1, Alberto Goday, John P Swann
1Harvard Medical School, Boston, MA 02143, USA. pcohen@challiance.org
American Journal of Public Health
|July 21, 2012
Summary
The FDA warns of dangerous weight loss supplements containing multiple pharmaceuticals. These "rainbow diet pills," with a history of fatalities, are resurfacing with new formulations.
Area of Science:
- Pharmacology
- Public Health
- History of Medicine
Background:
- The US Food and Drug Administration (FDA) has issued warnings regarding weight loss supplements adulterated with pharmaceutical agents.
- These supplements often combine anorectics (like amphetamine derivatives) with other drugs (benzodiazepines, beta-blockers) to mitigate side effects.
Observation:
- The adulterated weight loss supplements are the latest iteration of 'rainbow diet pills,' known for their colorful appearance and dating back over 70 years.
- First aggressively marketed in the 1940s by US pharmaceutical firms, these pills led to numerous deaths by the 1960s, prompting FDA intervention.
- The study traces the historical trajectory of these pills from their US origins to popularity in Spain and Brazil, and their subsequent re-emergence in the US market.
Findings:
- Analysis of original resources reveals a historical pattern of dangerous pharmaceutical adulteration in weight loss products.
- The evolution of 'rainbow diet pills' demonstrates a recurring public health risk associated with unregulated or illicitly formulated weight loss aids.
- The study highlights the persistence of these dangerous formulations across different eras and geographical locations.
Implications:
- Increased regulatory scrutiny and public awareness are crucial to prevent harm from adulterated weight loss supplements.
- Understanding the historical context of 'rainbow diet pills' can inform current strategies for combating counterfeit and dangerous health products.
- Further research into the specific pharmaceutical combinations and their long-term health effects in modern supplements is warranted.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

